NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
This year’s ISMO meeting heard presentations on a variety of high-quality cancer studies that have taken...
In this issue, highlights from the 2023 Gathering Around Cancer as well as national and international...
More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that...
Gathering Around Cancer, Croke Park Conference Centre, Dublin, 16-17 November 2023...
While some perceive peer review systems as “a soft touch”, the processes of the Organisation of...
Climate change will have an impact on the health system, including cancer care provision, the Gathering...
Therapeutic breakthroughs and the growth in importance of ‘personalised care’ were among the main themes...
The European Society for Medical Oncology and the American Society of Clinical Oncology (ESMO and ASCO)...
Results from a number of highly anticipated phase 3 clinical trials across the range of gynaecological...
Interim results from the phase 2 ENZA-p study (NCT04419402) show that adding 177Lu-PSMA-617 to enzalutamide...
Positive results from the TROPION-Breast01 phase 3 trial showed that a specifically engineered TROP2...
Shared decision-making is more than being attentive to patients’ needs or concerns – it also represents...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT